IBCSG conducts since 1977 academic clinical trials in early breast cancer, while respecting highest scientific and ethical standards. The patients are at the center of its considerations: the patient’s welfare and quality of life are important research topics.
IBCSG is dedicated to innovative clinical cancer research designed to improve the outcome of women with breast cancer. The goal of clinical research within IBCSG is to find answers to key questions. We wish to give our patients a longer survival, if we fail to cure, a longer symptom free period after the primary treatment and eventually to improve their quality of life.